{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/H",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Syst\u00E9mov\u00E1 hormon\u00E1ln\u00ED l\u00E9\u010Diva krom\u011B pohlavn\u00EDch hormon\u016F a inzulin\u016F" , "@language" : "cs" } ,        { "@value" : "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Hypofyz\u00E1rn\u00ED a hypotalamick\u00E9 hormony a analogy" , "@language" : "cs" } ,        { "@value" : "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES" , "@language" : "en" } ,        { "@value" : "Hormony p\u0159edn\u00EDho laloku hypof\u00FDzy a analogy" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01AC",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Somatropin and analogues" , "@language" : "en" } ,        { "@value" : "Somatropin a agonist\u00E9 somatropinu" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01AC" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01AC01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/H01A" ,        "http://linked.opendata.cz/resource/ATC/H" ,        "http://linked.opendata.cz/resource/ATC/H01" ,        "http://linked.opendata.cz/resource/ATC/H01AC" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Somatropin" , "@language" : "en" } ,        { "@value" : "Somatropin" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01AC01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000004102",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Intracranial hemorrhages" , "@language" : "en" } ,        { "@value" : "Intrakrani\u00E1ln\u00ED hemoragie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000609",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "N\u00E1dory mozku" , "@language" : "cs" } ,        { "@value" : "Brain neoplasms" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028842",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Human growth hormone" , "@language" : "en" } ,        { "@value" : "Lidsk\u00FD r\u016Fstov\u00FD hormon" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000004102" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000609" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/GENOTROPIN-16-M-J--5-3MG-",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028842" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "GENOTROPIN 16 M.J.(5,3MG)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0187293" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025166" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025167" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0187292" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0187293",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "GENOTROPIN 16 M.J.(5,3MG)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HORMONA (L\u00C9\u010CIVA S HORMON\u00C1LN\u00CD AKTIVITOU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC140264_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "5+5X1ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "16UT/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "D\u011ATI\nPoruchy r\u016Fstu zp\u016Fsoben\u00E9 nedostate\u010Dnou sekrec\u00ED r\u016Fstov\u00E9ho hormonu (growth hormone deficiency, GHD) a poruchy r\u016Fstu spojen\u00E9 s Turnerov\u00FDm syndromem nebo s chronickou ren\u00E1ln\u00ED nedostate\u010Dnost\u00ED.\nPoruchy r\u016Fstu (sou\u010Dasn\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu (SDS) < -2,5 a upraven\u00E1 rodi\u010Dovsk\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu < -1) u d\u011Bt\u00ED mal\u00E9ho vzr\u016Fstu, kter\u00E9 se narodily mal\u00E9 na sv\u016Fj gesta\u010Dn\u00ED v\u011Bk (SGA), s\u00A0porodn\u00ED v\u00E1hou a/nebo d\u00E9lkou pod \u20132SD, u kter\u00FDch se nedostav\u00ED r\u016Fstov\u00FD v\u00FD\u0161vih /catch-up growth/ (HV SDS < 0 b\u011Bhem posledn\u00EDho roku) do 4 let v\u011Bku nebo pozd\u011Bji.\nU Prader-Willi syndromu (PWS) ke zlep\u0161en\u00ED r\u016Fstu a skladby t\u011Bla. Diagn\u00F3za PWS by m\u011Bla b\u00FDt potvrzena p\u0159\u00EDslu\u0161n\u00FDmi genetick\u00FDmi testy.\nDOSP\u011AL\u00CD\nSubstitu\u010Dn\u00ED terapie u dosp\u011Bl\u00FDch s v\u00FDrazn\u00FDm deficitem r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0dosp\u011Bl\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED trp\u00ED t\u011B\u017Ek\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu s\u00A0v\u00EDcen\u00E1sobn\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu v d\u016Fsledku zn\u00E1m\u00E9ho hypothalamick\u00E9ho nebo hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED a \u00A0kte\u0159\u00ED maj\u00ED nedostatek nejm\u00E9n\u011B jednoho dal\u0161\u00EDho hypofyz\u00E1rn\u00EDho hormonu s\u00A0v\u00FDjimkou prolaktinu. U t\u011Bchto pacient\u016F by m\u011Bl b\u00FDt proveden vhodn\u00FD dynamick\u00FD test za \u00FA\u010Delem potvrzen\u00ED nebo vylou\u010Den\u00ED deficitu r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0d\u011Btsk\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED m\u011Bli v\u00A0d\u011Btstv\u00ED GHD v\u00A0d\u016Fsledku kongenit\u00E1ln\u00EDch, genetick\u00FDch, z\u00EDskan\u00FDch nebo idiopatick\u00FDch p\u0159\u00ED\u010Din. U pacient\u016F se vznikem deficitu r\u016Fstov\u00E9ho hormonu v\u00A0d\u011Btstv\u00ED je nutn\u00E9 znovu zhodnotit sekre\u010Dn\u00ED schopnost r\u016Fstov\u00E9ho hormonu po ukon\u010Den\u00ED axi\u00E1ln\u00EDho r\u016Fstu. U pacient\u016F s\u00A0velkou pravd\u011Bpodobnost\u00ED p\u0159etrv\u00E1vaj\u00EDc\u00EDho GHD, nap\u0159. z\u00A0kongenit\u00E1ln\u00EDch p\u0159\u00ED\u010Din nebo s GHD sekund\u00E1rn\u00EDho k hypothalamicko-hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED nebo maj\u00ED koncentraci IGF-I SDS ( -2, m\u016F\u017Ee b\u00FDt GHD pova\u017Eov\u00E1n za prok\u00E1zan\u00FD. V\u0161ichni ostatn\u00ED pacienti mus\u00ED podstoupit m\u011B\u0159en\u00ED hladin IGF-I a jeden test stimulace hormonu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2012-01-25" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 19058.66015625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 20716.669921875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ PSO LQF 5X16UT" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025166",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "GENOTROPIN 16 M.J.(5,3MG)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HORMONA (L\u00C9\u010CIVA S HORMON\u00C1LN\u00CD AKTIVITOU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC140267_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1+1X1ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "16UT/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "D\u011ATI\nPoruchy r\u016Fstu zp\u016Fsoben\u00E9 nedostate\u010Dnou sekrec\u00ED r\u016Fstov\u00E9ho hormonu (growth hormone deficiency, GHD) a poruchy r\u016Fstu spojen\u00E9 s Turnerov\u00FDm syndromem nebo s chronickou ren\u00E1ln\u00ED nedostate\u010Dnost\u00ED.\nPoruchy r\u016Fstu (sou\u010Dasn\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu (SDS) < -2,5 a upraven\u00E1 rodi\u010Dovsk\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu < -1) u d\u011Bt\u00ED mal\u00E9ho vzr\u016Fstu, kter\u00E9 se narodily mal\u00E9 na sv\u016Fj gesta\u010Dn\u00ED v\u011Bk (SGA), s\u00A0porodn\u00ED v\u00E1hou a/nebo d\u00E9lkou pod \u20132SD, u kter\u00FDch se nedostav\u00ED r\u016Fstov\u00FD v\u00FD\u0161vih /catch-up growth/ (HV SDS < 0 b\u011Bhem posledn\u00EDho roku) do 4 let v\u011Bku nebo pozd\u011Bji.\nU Prader-Willi syndromu (PWS) ke zlep\u0161en\u00ED r\u016Fstu a skladby t\u011Bla. Diagn\u00F3za PWS by m\u011Bla b\u00FDt potvrzena p\u0159\u00EDslu\u0161n\u00FDmi genetick\u00FDmi testy.\nDOSP\u011AL\u00CD\nSubstitu\u010Dn\u00ED terapie u dosp\u011Bl\u00FDch s v\u00FDrazn\u00FDm deficitem r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0dosp\u011Bl\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED trp\u00ED t\u011B\u017Ek\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu s\u00A0v\u00EDcen\u00E1sobn\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu v d\u016Fsledku zn\u00E1m\u00E9ho hypothalamick\u00E9ho nebo hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED a \u00A0kte\u0159\u00ED maj\u00ED nedostatek nejm\u00E9n\u011B jednoho dal\u0161\u00EDho hypofyz\u00E1rn\u00EDho hormonu s\u00A0v\u00FDjimkou prolaktinu. U t\u011Bchto pacient\u016F by m\u011Bl b\u00FDt proveden vhodn\u00FD dynamick\u00FD test za \u00FA\u010Delem potvrzen\u00ED nebo vylou\u010Den\u00ED deficitu r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0d\u011Btsk\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED m\u011Bli v\u00A0d\u011Btstv\u00ED GHD v\u00A0d\u016Fsledku kongenit\u00E1ln\u00EDch, genetick\u00FDch, z\u00EDskan\u00FDch nebo idiopatick\u00FDch p\u0159\u00ED\u010Din. U pacient\u016F se vznikem deficitu r\u016Fstov\u00E9ho hormonu v\u00A0d\u011Btstv\u00ED je nutn\u00E9 znovu zhodnotit sekre\u010Dn\u00ED schopnost r\u016Fstov\u00E9ho hormonu po ukon\u010Den\u00ED axi\u00E1ln\u00EDho r\u016Fstu. U pacient\u016F s\u00A0velkou pravd\u011Bpodobnost\u00ED p\u0159etrv\u00E1vaj\u00EDc\u00EDho GHD, nap\u0159. z\u00A0kongenit\u00E1ln\u00EDch p\u0159\u00ED\u010Din nebo s GHD sekund\u00E1rn\u00EDho k hypothalamicko-hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED nebo maj\u00ED koncentraci IGF-I SDS ( -2, m\u016F\u017Ee b\u00FDt GHD pova\u017Eov\u00E1n za prok\u00E1zan\u00FD. V\u0161ichni ostatn\u00ED pacienti mus\u00ED podstoupit m\u011B\u0159en\u00ED hladin IGF-I a jeden test stimulace hormonu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ PSO LQF 1X16UT" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0025167",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "GENOTROPIN 16 M.J.(5,3MG)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HORMONA (L\u00C9\u010CIVA S HORMON\u00C1LN\u00CD AKTIVITOU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC140267_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "5+5X1ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "16UT/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "D\u011ATI\nPoruchy r\u016Fstu zp\u016Fsoben\u00E9 nedostate\u010Dnou sekrec\u00ED r\u016Fstov\u00E9ho hormonu (growth hormone deficiency, GHD) a poruchy r\u016Fstu spojen\u00E9 s Turnerov\u00FDm syndromem nebo s chronickou ren\u00E1ln\u00ED nedostate\u010Dnost\u00ED.\nPoruchy r\u016Fstu (sou\u010Dasn\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu (SDS) < -2,5 a upraven\u00E1 rodi\u010Dovsk\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu < -1) u d\u011Bt\u00ED mal\u00E9ho vzr\u016Fstu, kter\u00E9 se narodily mal\u00E9 na sv\u016Fj gesta\u010Dn\u00ED v\u011Bk (SGA), s\u00A0porodn\u00ED v\u00E1hou a/nebo d\u00E9lkou pod \u20132SD, u kter\u00FDch se nedostav\u00ED r\u016Fstov\u00FD v\u00FD\u0161vih /catch-up growth/ (HV SDS < 0 b\u011Bhem posledn\u00EDho roku) do 4 let v\u011Bku nebo pozd\u011Bji.\nU Prader-Willi syndromu (PWS) ke zlep\u0161en\u00ED r\u016Fstu a skladby t\u011Bla. Diagn\u00F3za PWS by m\u011Bla b\u00FDt potvrzena p\u0159\u00EDslu\u0161n\u00FDmi genetick\u00FDmi testy.\nDOSP\u011AL\u00CD\nSubstitu\u010Dn\u00ED terapie u dosp\u011Bl\u00FDch s v\u00FDrazn\u00FDm deficitem r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0dosp\u011Bl\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED trp\u00ED t\u011B\u017Ek\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu s\u00A0v\u00EDcen\u00E1sobn\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu v d\u016Fsledku zn\u00E1m\u00E9ho hypothalamick\u00E9ho nebo hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED a \u00A0kte\u0159\u00ED maj\u00ED nedostatek nejm\u00E9n\u011B jednoho dal\u0161\u00EDho hypofyz\u00E1rn\u00EDho hormonu s\u00A0v\u00FDjimkou prolaktinu. U t\u011Bchto pacient\u016F by m\u011Bl b\u00FDt proveden vhodn\u00FD dynamick\u00FD test za \u00FA\u010Delem potvrzen\u00ED nebo vylou\u010Den\u00ED deficitu r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0d\u011Btsk\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED m\u011Bli v\u00A0d\u011Btstv\u00ED GHD v\u00A0d\u016Fsledku kongenit\u00E1ln\u00EDch, genetick\u00FDch, z\u00EDskan\u00FDch nebo idiopatick\u00FDch p\u0159\u00ED\u010Din. U pacient\u016F se vznikem deficitu r\u016Fstov\u00E9ho hormonu v\u00A0d\u011Btstv\u00ED je nutn\u00E9 znovu zhodnotit sekre\u010Dn\u00ED schopnost r\u016Fstov\u00E9ho hormonu po ukon\u010Den\u00ED axi\u00E1ln\u00EDho r\u016Fstu. U pacient\u016F s\u00A0velkou pravd\u011Bpodobnost\u00ED p\u0159etrv\u00E1vaj\u00EDc\u00EDho GHD, nap\u0159. z\u00A0kongenit\u00E1ln\u00EDch p\u0159\u00ED\u010Din nebo s GHD sekund\u00E1rn\u00EDho k hypothalamicko-hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED nebo maj\u00ED koncentraci IGF-I SDS ( -2, m\u016F\u017Ee b\u00FDt GHD pova\u017Eov\u00E1n za prok\u00E1zan\u00FD. V\u0161ichni ostatn\u00ED pacienti mus\u00ED podstoupit m\u011B\u0159en\u00ED hladin IGF-I a jeden test stimulace hormonu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 19058.66015625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 20716.669921875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ PSO LQF 5X16UT" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0187292",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "GENOTROPIN 16 M.J.(5,3MG)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HORMONA (L\u00C9\u010CIVA S HORMON\u00C1LN\u00CD AKTIVITOU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC140264_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1+1X1ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "16UT/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "D\u011ATI\nPoruchy r\u016Fstu zp\u016Fsoben\u00E9 nedostate\u010Dnou sekrec\u00ED r\u016Fstov\u00E9ho hormonu (growth hormone deficiency, GHD) a poruchy r\u016Fstu spojen\u00E9 s Turnerov\u00FDm syndromem nebo s chronickou ren\u00E1ln\u00ED nedostate\u010Dnost\u00ED.\nPoruchy r\u016Fstu (sou\u010Dasn\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu (SDS) < -2,5 a upraven\u00E1 rodi\u010Dovsk\u00E1 sm\u011Brodatn\u00E1 odchylka r\u016Fstu < -1) u d\u011Bt\u00ED mal\u00E9ho vzr\u016Fstu, kter\u00E9 se narodily mal\u00E9 na sv\u016Fj gesta\u010Dn\u00ED v\u011Bk (SGA), s\u00A0porodn\u00ED v\u00E1hou a/nebo d\u00E9lkou pod \u20132SD, u kter\u00FDch se nedostav\u00ED r\u016Fstov\u00FD v\u00FD\u0161vih /catch-up growth/ (HV SDS < 0 b\u011Bhem posledn\u00EDho roku) do 4 let v\u011Bku nebo pozd\u011Bji.\nU Prader-Willi syndromu (PWS) ke zlep\u0161en\u00ED r\u016Fstu a skladby t\u011Bla. Diagn\u00F3za PWS by m\u011Bla b\u00FDt potvrzena p\u0159\u00EDslu\u0161n\u00FDmi genetick\u00FDmi testy.\nDOSP\u011AL\u00CD\nSubstitu\u010Dn\u00ED terapie u dosp\u011Bl\u00FDch s v\u00FDrazn\u00FDm deficitem r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0dosp\u011Bl\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED trp\u00ED t\u011B\u017Ek\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu s\u00A0v\u00EDcen\u00E1sobn\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu v d\u016Fsledku zn\u00E1m\u00E9ho hypothalamick\u00E9ho nebo hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED a \u00A0kte\u0159\u00ED maj\u00ED nedostatek nejm\u00E9n\u011B jednoho dal\u0161\u00EDho hypofyz\u00E1rn\u00EDho hormonu s\u00A0v\u00FDjimkou prolaktinu. U t\u011Bchto pacient\u016F by m\u011Bl b\u00FDt proveden vhodn\u00FD dynamick\u00FD test za \u00FA\u010Delem potvrzen\u00ED nebo vylou\u010Den\u00ED deficitu r\u016Fstov\u00E9ho hormonu. \nVznik v\u00A0d\u011Btsk\u00E9m v\u011Bku: Pacienti, kte\u0159\u00ED m\u011Bli v\u00A0d\u011Btstv\u00ED GHD v\u00A0d\u016Fsledku kongenit\u00E1ln\u00EDch, genetick\u00FDch, z\u00EDskan\u00FDch nebo idiopatick\u00FDch p\u0159\u00ED\u010Din. U pacient\u016F se vznikem deficitu r\u016Fstov\u00E9ho hormonu v\u00A0d\u011Btstv\u00ED je nutn\u00E9 znovu zhodnotit sekre\u010Dn\u00ED schopnost r\u016Fstov\u00E9ho hormonu po ukon\u010Den\u00ED axi\u00E1ln\u00EDho r\u016Fstu. U pacient\u016F s\u00A0velkou pravd\u011Bpodobnost\u00ED p\u0159etrv\u00E1vaj\u00EDc\u00EDho GHD, nap\u0159. z\u00A0kongenit\u00E1ln\u00EDch p\u0159\u00ED\u010Din nebo s GHD sekund\u00E1rn\u00EDho k hypothalamicko-hypofyz\u00E1rn\u00EDho onemocn\u011Bn\u00ED nebo maj\u00ED koncentraci IGF-I SDS ( -2, m\u016F\u017Ee b\u00FDt GHD pova\u017Eov\u00E1n za prok\u00E1zan\u00FD. V\u0161ichni ostatn\u00ED pacienti mus\u00ED podstoupit m\u011B\u0159en\u00ED hladin IGF-I a jeden test stimulace hormonu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ PSO LQF 1X16UT" , "@language" : "cs" } ] }] }